Topics and Expertise: Genome-Wide Association Study

UCSF School of Pharmacy leads in NIH funding for 37th year in a row

For the 37th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. School researchers were awarded $28.2 million in grants during NIH’s 2016 fiscal year, from October 1, 2015 to...

Ahituv, Kaiser Permanente study identifies genetic susceptibility for hernia

Research in the lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, in collaboration with the Kaiser Permanente Division of Research and others, has identified variations at four locations in the genome underlying risk for the most common type of abdominal hernia.

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Study discovers why leading gout medication is ineffective for many

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.